Clinical Trial Update: Second-line Standard Treatment Sequential TAS-102 and Bevacizumab Combined With Local Treatment in Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sequential TAS-102 and bevacizumab, in combination with local treatment, as second-line therapy for advanced/metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 2 | Status: RECRUITING